NCT02248961
Efficacy and Safety Evaluating Study to Compare Kanarb (Fimasartan) and Cozaar® (Losartan) in Adult Patients With Grade I-II Arterial Hypertension
See it on ClinicalTrials.gov ↗179 people
35.8%
64.2%
64 womenmiddle line = equal numbers115 men
- Phase
- PHASE3
- Paid for by
- R-Pharm
- Finished
- 2015-08
- Health conditions
- Arterial Hypertension
- Who could join
- Anyone
- Ages
- 18 Years – 75 Years
- Average age
- mean 53.6 years
- Age 65+
- Not reported
- Weight (BMI)
- mean 29.1 kg/m^2
- Pregnancy recorded
- Not reported
- Menopause recorded
- Not reported
- Results shown by sex
- Not split by sex
- Race
- White 98.9% · Asian 1.1%
Women left out
- No pregnant women
Women who were pregnant could not join.
“Pregnancy or breast-feeding period; fertile women not using adequate contraception methods”
- No breastfeeding moms
Women who were breastfeeding could not join.
“Pregnancy or breast-feeding period; fertile women not using adequate contraception methods”
- Had to use birth control
Women who couldn't or didn't want to use birth control were turned away.
“Pregnancy or breast-feeding period; fertile women not using adequate contraception methods”
- No kidney or liver problems
Women with kidney or liver problems were turned away.
“Creatinine clearance less than 60 ml/min/1.73m2 calculated by Cockroft-Gault formula.”
- No heart disease
Women with heart disease, heart rhythm problems or a past heart attack were turned away.
“Myocardial infarction and or unstable angina, and/or acute cerebrovascular accident/transient ischemic attack, and/or percutaneous coronary intervention, and/or coronary arterial bypass graft, acute coronary arteries involvement, and/or obl…”
- No diabetes
Women with diabetes were turned away.
“Uncontrolled Diabetes mellitus, Glycosylated hemoglobin level (HbA1c) \>7%.”
- No mental health conditions
Women with depression, bipolar disorder or other mental health conditions were turned away.
“Drug or alcohol addiction, psychiatric disorders.”
- No cancer
Women with current or past cancer were turned away.
“Medical history of oncological disease within 5 years before screening.”
Study titles and rules are shown in their original English.